Disseminated medullary thyroid carcinoma. Optimal approach to treatment

Abstract

Medullary thyroid cancer is a rare tumor. Due to variability of its biological behavior, treatment of this tumor often is a complicated problem. Clinicians have difficulties with determination of indications for prescription of tyrosine kinase inhibitors. Prescription should be based on scru-tinous monitoring of the patients and consideration of all factors: level of tumor markers, patient’s state, and data form visual examinations.

Keywords

• medullary thyroid cancer
• tyrosine kinase inhibitors
• indications
• vandetanib